AQR Arbitrage’s Integrated Wellness Acquisition Corp Redeemable Warrants WEL.WS Stock Holding History

AQR Arbitrage’s Portfolio WEL.WS Stock Details WEL.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-237,873	Closed	-$4.76K	–	561
2024 Q3	$4.76K	Hold	237,873	–	–	﹤0.01%	477
2024 Q2	$3.59K	Hold	237,873	–	–	﹤0.01%	521
2024 Q1	$8.35K	Hold	237,873	–	–	﹤0.01%	491
2023 Q4	$8.33K	Hold	237,873	–	–	﹤0.01%	530
2023 Q3	$89.2K	Hold	237,873	–	–	﹤0.01%	422
2023 Q2	$200K	Sell	237,873 -10,675	-4%	-$8.81K	0.01%	473
2023 Q1	$237K	Sell	248,548 -200	-0.1%	-$109	0.01%	542
2022 Q4	$12.4K	Hold	248,748	–	–	﹤0.01%	900
2022 Q3	$63K	Hold	248,748	–	–	﹤0.01%	834
2022 Q2	$42K	Buy	248,748 +3,750	+2%	+$939	﹤0.01%	925
2022 Q1	$88K	Buy	+244,998	New	+$87.6K	﹤0.01%	806

Other funds holding WEL.WS

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

AQR Arbitrage's WEL.WS Position: Q4 2024 in Review

AQR Arbitrage sold out of Integrated Wellness Acquisition Corp Redeemable Warrants (WEL.WS) in Q4 2024, closing a stake of 237,873 shares — an estimated $4.76K sold.

AQR Arbitrage first reported a position in WEL.WS in Q1 2022 and held it in 11 quarters. The position peaked at $237K in Q1 2023. 1 fund tracked by Wall St. Rank holds WEL.WS as of Q4 2024.

AQR Arbitrage reported no remaining Integrated Wellness Acquisition Corp Redeemable Warrants position as of Q4 2024 after selling out during the quarter.
AQR Arbitrage sold 237,873 Integrated Wellness Acquisition Corp Redeemable Warrants shares in Q4 2024, an estimated $4.76K.
AQR Arbitrage first reported a position in Integrated Wellness Acquisition Corp Redeemable Warrants in Q1 2022 and held it in 11 quarters.
AQR Arbitrage's Integrated Wellness Acquisition Corp Redeemable Warrants position peaked at $237K in Q1 2023.
1 fund tracked by Wall St. Rank held Integrated Wellness Acquisition Corp Redeemable Warrants as of Q4 2024.

Based on AQR Arbitrage's 13F filing for Q4 2024, filed 14 Feb 2025.